© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

Treatment News

Curing Hepatitis C Is Associated With a Reduced Risk of Death
Hepatitis C Medications
Forums: Support and discussion

FDA Approves New Drug for Liver Cancer

With the approval of Cyramza, there are now five targeted therapies for hepatocellular carcinoma.

Those Not Cured by Hep C Treatment See Worse Health-Related Quality of Life

This finding was especially pronounced among those with cirrhosis, a history of depression, liver disease progression or liver cancer.

Hepatitis A Cases Have Surged 4-Fold in Just a Few Years

The CDC has released a new hepatitis A surveillance report.

Hep C Rates Are High Among Both Older and Younger Drug Injectors

Just over half of people who use drugs in eight cities are hepatitis C virus antibody positive.

Researchers Make Progress in Developing Oral Hepatitis B Vaccine

Such a vaccine would make inoculation easier in developing nations, where the need is great.

Directly Observed Hep C Treatment Ups Adherence in People Who Inject Drugs

This is compared with providing people who inject drugs with hep C drugs to take independently.

MUST read

Celebrities With Hepatitis
10 Tips to Protect Your Liver
Hep Stories: Get inspired
The 2017 Hepatitis C Treatment Pipeline
EASL 2017 Roundup: Continued Progress in Fighting Liver Disease
11 Signs of Liver Disease
Hepatitis B virus

Entry Inhibitor Could Potentially Cure Hepatitis B and D

Bulevirtide plus pegylated interferon shows promise for hard-to-treat coinfection.

FDA OKs AbbVie’s Mavyret for Adolescents With Hepatitis C

The approval applies to those between 12 and 17 years old who have any of the six genotypes of the virus.

Paper Claiming Viread Bests Baraclude as Hep B Treatment Is Retracted

The drug is still associated with a lower liver cancer rate than Baraclude.

International Liver Congress Roundup

A quick overview of Hep Magazine’s reporting on the 53rd International Liver Congress in Vienna

Experimental NASH Drug Fails in Late-Stage Study

Selonsertib did not improve liver fibrosis more than a placebo.

Hot topics

Hepatitis C: The Basics
Hepatitis B: The Basics
Hepatitis A: The Basics
NASH: The Basics

Only a Few High-Income Nations Poised to Hit WHO’s Hep C Elimination Targets

The World Health Organization has set various benchmarks for nations to hit in controlling their epidemics by 2030.

Hep C Testing and Treatment Rates Are High Among Australians Who Inject Drugs

The nation has provided unrestricted access to hepatitis C treatment since 2016.

More Confirmation That Hep C Treatment Is Highly Effective in Those With HIV

Researchers conducted an analysis of hep C treatment outcomes in those also living with HIV in Western nations.

FDA OKs First Generic Naloxone Nasal Spray for Opioid Overdose

The spray requires no medical training.

Harvoni Is Safe and Effective for Those With Advanced Liver Disease

Curing the virus was associated with a lower risk of liver cancer recurrence.
Advertisement
Newsfeed
Features
Hep Stories
Treatment News

Hot topics

Forums: Support and discussion
Blogs: The community speaks
Hep Stories: Get inspired
Magazine: Search the archives
#Coffee
A smiling Caucasian couple
#BabyBoomers